Regulation of L1 expression and retrotransposition by melatonin and its receptor: Implications for cancer risk associated with light exposure at night

Nucleic Acids Research

Volumn 42, Issue 12, 2014, Pages 7694-7707

  Deharo, Dawn ^a   Kines, Kristine J ^a   Sokolowski, Mark ^a   Dauchy, Robert T ^a   Streva, Vincent A ^a   Hill, Steven M ^a   Hanifin, John P ^b   Brainard, George C ^b   Blask, David E ^a   Belancio, Victoria P ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; MELATONIN 1 RECEPTOR; MESSENGER RNA; NUCLEIC ACID; PROTEIN ORF1; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIGHT EXPOSURE; LONG INTERSPERSED REPEAT; MALE; NIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETROPOSON; SHIFT WORKER; TISSUE CULTURE;

ALU ELEMENTS; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; DARKNESS; HUMANS; LIGHT; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MELATONIN; MUTATION; NEOPLASMS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEINS; RATS; RECEPTOR, MELATONIN, MT1; RISK; RNA, MESSENGER; UBIQUITINATION;

EID: 84903979440     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku503     Document Type: Article

References (93)

1. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
2. Waterston, R.H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J.F., Agarwal, P., Agarwala, R., Ainscough, R., Alexandersson, M., An, P. et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature, 420, 520-562.
3. Belancio, V.P., Roy-Engel, A.M., Pochampally, R.R., Deininger, P. (2010) Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res., 38, 3909-3922.
4. Evrony, G.D., Cai, X., Lee, E., Hills, L.B., Elhosary, P.C., Lehmann, H.S., Parker, J.J., Atabay, K.D., Gilmore, E.C., Poduri, A. et al. (2012) Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell, 151, 483-496.
5. Solyom, S., Ewing, A.D., Rahrmann, E.P., Doucet, T.T., Nelson, H.H., Burns, M.B., Harris, R.S., Sigmon, D.F., Casella, A., Erlanger, B. et al. (2012) Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res., 22, 2328-2338.
6. Moran, J.V., Holmes, S.E., Naas, T.P., DeBerardinis, R.J., Boeke, J.D., Kazazian, H.H. Jr (1996) High frequency retrotransposition in cultured mammalian cells. Cell, 87, 917-927.
7. Martin, S.L. (1991) Ribonucleoprotein particles with LINE-1 RNA in mouse embryonal carcinoma cells. Mol. Cell Biol., 11, 4804-4807.
8. Martin, S.L., Branciforte, D., Keller, D., Bain, D.L. (2003) Trimeric structure for an essential protein in L1 retrotransposition. Proc. Natl. Acad. Sci. U.S.A., 100, 13815-13820.
9. Kolosha, V.O., Martin, S.L. (2003) High-affinity, non-sequence-specific RNA binding by the open reading frame 1 (ORF1) protein from long interspersed nuclear element 1 (LINE-1). J. Biol. Chem., 278, 8112-8117.
10. Khazina, E., Truffault, V., Buttner, R., Schmidt, S., Coles, M., Weichenrieder, O. (2011) Trimeric structure and flexibility of the L1ORF1 protein in human L1 retrotransposition. Nat. Struct. Mol. Biol., 18, 1006-1014.
11. Martin, S.L., Bushman, F.D. (2001) Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol. Cell Biol., 21, 467-475.
12. Cost, G.J., Boeke, J.D. (1998) Targeting of human retrotransposon integration is directed by the specificity of the L1 endonuclease for regions of unusual DNA structure. Biochemistry, 37, 18081-18093.
13. Feng, Q., Moran, J.V., Kazazian, H.H. Jr and Boeke, J.D. (1996) Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell, 87, 905-916.
14. Martin, S.L., Li, J., Epperson, L.E., Lieberman, B. (1998) Functional reverse transcriptases encoded by A-type mouse LINE-1: defining the minimal domain by deletion analysis. Gene, 215, 69-75.
15. Piskareva, O., Ernst, C., Higgins, N., Schmatchenko, V. (2013) The carboxy-terminal segment of the human LINE-1 ORF2 protein is involved in RNA binding. FEBS Open Bio., 3, 433-437.
16. Belancio, V.P., Roy-Engel, A.M., Deininger, P.L. (2010) All y'all need to know ?bout retroelements in cancer. Semin. Cancer Biol., 20, 200-210.
17. Gasior, S.L., Wakeman, T.P., Xu, B., Deininger, P.L. (2006) The human LINE-1 retrotransposon creates DNA double-strand breaks. J. Mol. Biol., 357, 1383-1393.
18. Belancio, V.P., Hedges, D.J., Deininger, P. (2008) Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res., 18, 343-358.
19. Dewannieux, M., Esnault, C., Heidmann, T. (2003) LINE-mediated retrotransposition of marked Alu sequences. Nat. Genet., 35, 41-48.
20. Hancks, D.C., Goodier, J.L., Mandal, P.K., Cheung, L.E., Kazazian, H.H. Jr (2011) Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum. Mol. Genet., 20, 3386-3400.
21. Hsieh, S.Y., Chen, W.Y., Yeh, T.S., Sheen, I.S., Huang, S.F. (2005) High-frequency Alu-mediated genomic recombination/deletion within the caspase-activated DNase gene in human hepatoma. Oncogene, 24, 6584-6589.
22. Lee, E., Iskow, R., Yang, L., Gokcumen, O., Haseley, P., Luquette, L.J. III, Lohr, J.G., Harris, C.C., Ding, L., Wilson, R.K. et al. (2012) Landscape of somatic retrotransposition in human cancers. Science, 337, 967-971.
23. Lin, C., Yang, L., Tanasa, B., Hutt, K., Ju, B.G., Ohgi, K., Zhang, J., Rose, D.W., Fu, X.D., Glass, C.K. et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell, 139, 1069-1083.
24. Iskow, R.C., McCabe, M.T., Mills, R.E., Torene, S., Pittard, W.S., Neuwald, A.F., Van Meir, E.G., Vertino, P.M., Devine, S.E. (2010) Natural mutagenesis of human genomes by endogenous retrotransposons. Cell, 141, 1253-1261.
25. Hata, K., Sakaki, Y. (1997) Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene, 189, 227-234.
26. Bourc'his, D., Bestor, T.H. (2004) Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature, 431, 96-99.
27. Athanikar, J.N., Badge, R.M., Moran, J.V. (2004) A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res., 32, 3846-3855.
28. Belancio, V.P., Hedges, D.J., Deininger, P. (2006) LINE-1 RNA splicing and influences on mammalian gene expression. Nucleic Acids Res., 34, 1512-1521.
29. Gasior, S.L., Roy-Engel, A.M., Deininger, P.L. (2008) ERCC1/XPF limits L1 retrotransposition. DNA Repair (Amst), 7, 983-989.
30. Perepelitsa-Belancio, V., Deininger, P. (2003) RNA truncation by premature polyadenylation attenuates human mobile element activity. Nat. Genet., 35, 363-366.
31. Yang, N., Zhang, L., Zhang, Y., Kazazian, H.H. (2003) An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res., 31, 4929-4940.
32. Wu, J., Dauchy, R.T., Tirrell, P.C., Wu, S.S., Lynch, D.T., Jitawatanarat, P., Burrington, C.M., Dauchy, E.M., Blask, D.E., Greene, M.W. (2011) Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenografts. Cancer Res., 71, 2622-2631.
33. Kang, T.H., Reardon, J.T., Kemp, M., Sancar, A. (2009) Circadian oscillation of nucleotide excision repair in mammalian brain. Proc. Natl. Acad. Sci. U.S.A., 106, 2864-2867.
34. Poirel, V.J., Masson-Pevet, M., Pevet, P., Gauer, F. (2002) MT1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei. Brain Res., 946, 64-71.
35. Poirel, V.J., Cailotto, C., Streicher, D., Pevet, P., Masson-Pevet, M., Gauer, F. (2003) MT1 melatonin receptor mRNA tissular localization by PCR amplification. Neuro. Endocrinol. Lett., 24, 33-38.
36. Aust, S., Jager, W., Kirschner, H., Klimpfinger, M., Thalhammer, T. (2008) Pancreatic stellate/myofibroblast cells express G-protein-coupled melatonin receptor 1. Wien. Med. Wochenschr., 158, 575-578.
37. Aust, S., Thalhammer, T., Humpeler, S., Jager, W., Klimpfinger, M., Tucek, G., Obrist, P., Marktl, W., Penner, E., Ekmekcioglu, C. (2004) The melatonin receptor subtype MT1 is expressed in human gallbladder epithelia. J. Pineal Res., 36, 43-48.
38. Dillon, D.C., Easley, S.E., Asch, B.B., Cheney, R.T., Brydon, L., Jockers, R., Winston, J.S., Brooks, J.S., Hurd, T., Asch, H.L. (2002) Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am. J. Clin. Pathol., 118, 451-458.
39. Jablonska, K., Pula, B., Zemla, A., Owczarek, T., Wojnar, A., Rys, J., Ambicka, A., Podhorska-Okolow, M., Ugorski, M., Dziegiel, P. (2013) Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma. J. Pineal Res., 54, 334-345.
40. Richter, H.G., Torres-Farfan, C., Garcia-Sesnich, J., Abarzua-Catalan, L., Henriquez, M.G., Alvarez-Felmer, M., Gaete, F., Rehren, G.E., Seron-Ferre, M. (2008) Rhythmic expression of functional MT1 melatonin receptors in the rat adrenal gland. Endocrinology, 149, 995-1003.
41. Hardeland, R., Madrid, J.A., Tan, D.X., Reiter, R.J. (2012) Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J. Pineal Res., 52, 139-166.
42. Lewy, A.J., Wehr, T.A., Goodwin, F.K., Newsome, D.A., Markey, S.P. (1980) Light suppresses melatonin secretion in humans. Science, 210, 1267-1269.
43. Stevens, R.G. (2009) Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int. J. Epidemiol., 38, 963-970.
44. Zhu, Y., Stevens, R.G., Hoffman, A.E., Fitzgerald, L.M., Kwon, E.M., Ostrander, E.A., Davis, S., Zheng, T., Stanford, J.L. (2009) Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res., 69, 9315-9322.
45. Anisimov, V.N., Alimova, I.N., Baturin, D.A., Popovich, I.G., Zabezhinski, M.A., Manton, K.G., Semenchenko, A.V., Yashin, A.I. (2003) The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int. J. Cancer, 103, 300-305.
46. Dauchy, R.T., Blask, D.E., Sauer, L.A., Brainard, G.C., Krause, J.A. (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett., 144, 131-136.
47. Straif, K., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., Altieri, A., Benbrahim-Tallaa, L., Cogliano, V. (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol., 8, 1065-1066.
48. Alisch, R.S., Garcia-Perez, J.L., Muotri, A.R., Gage, F.H., Moran, J.V. (2006) Unconventional translation of mammalian LINE-1 retrotransposons. Genes Dev., 20, 210-224.
49. Goodier, J.L., Zhang, L., Vetter, M.R., Kazazian, H.H. Jr (2007) LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol. Cell Biol., 27, 6469-6483.
50. Kroutter, E.N., Belancio, V.P., Wagstaff, B.J., Roy-Engel, A.M. (2009) The RNA polymerase dictates ORF1 requirement and timing of LINE and SINE retrotransposition. PLoS Genet., 5, e1000458.
51. Sokolowski, M., Deharo, D., Christian, C.M., Kines, K.J., Belancio, V.P. (2013) Characterization of L1 ORF1p self-interaction and cellular localization using a mammalian two-hybrid system. PLoS One, 8, e82021.
52. Belancio, V.P. (2011) Importance of RNA analysis in interpretation of reporter gene expression data. Anal. Biochem., 417, 159-161.
53. Yuan, L., Collins, A.R., Dai, J., Dubocovich, M.L., Hill, S.M. (2002) MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol. Cell Endocrinol., 192, 147-156.
54. Blom, N., Gammeltoft, S., Brunak, S. (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol., 294, 1351-1362.
55. Chen, Z., Chen, Y.Z., Wang, X.F., Wang, C., Yan, R.X., Zhang, Z. (2011) Prediction of ubiquitination sites by using the composition of k-spaced amino acid pairs. PLoS One, 6, e22930.
56. Dauchy, R.T., Sauer, L.A. (1986) Preparation of "tissue- isolated" rat tumors for perfusion: a new surgical technique that preserves continuous blood flow. Lab. Anim. Sci., 36, 678-681.
57. Dauchy, R.T., Dauchy, E.M., Mao, L., Belancio, V.P., Hill, S.M., Blask, D.E. (2012) A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats. Comp. Med., 62, 99-108.
58. Blask, D.E., Brainard, G.C., Dauchy, R.T., Hanifin, J.P., Davidson, L.K., Krause, J.A., Sauer, L.A., Rivera-Bermudez, M.A., Dubocovich, M.L., Jasser, S.A. et al. (2005) Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res., 65, 11174-11184.
59. Gonzalez, A., Martinez-Campa, C., Mediavilla, M.D., Alonso-Gonzalez, C., Sanchez-Mateos, S., Hill, S.M., Sanchez-Barcelo, E.J., Cos, S. (2007) Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells. Oncol. Rep., 17, 947-953.
60. Bonde, J.P., Hansen, J., Kolstad, H.A., Mikkelsen, S., Olsen, J.H., Blask, D.E., Harma, M., Kjuus, H., de Koning, H.J., Olsen, J. et al. (2012) Work at night and breast cancer|-report on evidence-based options for preventive actions. Scand. J. Work Environ. Health, 38, 380-390.
61. Davis, S.,Mirick, D.K. (2006) Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control, 17, 539-545.
62. Stevens, R.G., Hansen, J., Costa, G., Haus, E., Kauppinen, T., Aronson, K.J., Castano-Vinyals, G., Davis, S., Frings-Dresen, M.H., Fritschi, L. et al. (2011) Considerations of circadian impact for defining ?shift work? in cancer studies: IARC Working Group Report. Occup. Environ. Med., 68, 154-162.
63. Nemeth, C., Humpeler, S., Kallay, E., Mesteri, I., Svoboda, M., Rogelsperger, O., Klammer, N., Thalhammer, T., Ekmekcioglu, C. (2011) Decreased expression of the melatonin receptor 1 in human colorectal adenocarcinomas. J. Biol. Regul. Homeost. Agents, 25, 531-542.
64. Toma, C.D., Svoboda, M., Arrich, F., Ekmekcioglu, C., Assadian, O., Thalhammer, T. (2007) Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors. J. Pineal Res., 43, 206-213.
65. Nakamura, E., Kozaki, K., Tsuda, H., Suzuki, E., Pimkhaokham, A., Yamamoto, G., Irie, T., Tachikawa, T., Amagasa, T., Inazawa, J. et al. (2008) Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma. Cancer Sci., 99, 1390-1400.
66. Oprea-Ilies, G., Haus, E., Sackett-Lundeen, L., Liu, Y., McLendon, L., Busch, R., Adams, A., Cohen, C. (2013) Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival. Breast Cancer Res. Treat., 137, 677-687.
67. Wallace, N.A., Belancio, V.P., Deininger, P.L. (2008) L1 mobile element expression causes multiple types of toxicity. Gene, 419, 75-81.
68. Lamia, K.A., Sachdeva, U.M., DiTacchio, L., Williams, E.C., Alvarez, J.G., Egan, D.F., Vasquez, D.S., Juguilon, H., Panda, S., Shaw, R.J. et al. (2009) AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science, 326, 437-440.
69. Sauer, L.A., Stayman, J.W. III and Dauchy, R.T. (1982) Amino acid, glucose, and lactic acid utilization in vivo by rat tumors. Cancer Res., 42, 4090-4097.
70. Davis, S., Mirick, D.K., Stevens, R.G. (2001) Night shift work, light at night, and risk of breast cancer. J. Natl. Cancer Inst., 93, 1557-1562.
71. Menegaux, F., Truong, T., Anger, A., Cordina-Duverger, E., Lamkarkach, F., Arveux, P., Kerbrat, P., Fevotte, J., Guenel, P. (2013) Night work and breast cancer: a population-based case-control study in France (the CECILE study). Int. J. Cancer, 132, 924-931.
72. Anisimov, V.N., Baturin, D.A., Popovich, I.G., Zabezhinski, M.A., Manton, K.G., Semenchenko, A.V., Yashin, A.I. (2004) Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice. Int. J. Cancer, 111, 475-479.
73. Burrell, R.A., McGranahan, N., Bartek, J., Swanton, C. (2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature, 501, 338-345.
74. Harris, C.R., Normart, R., Yang, Q., Stevenson, E., Haffty, B.G., Ganesan, S., Cordon-Cardo, C., Levine, A.J., Tang, L.H. (2010) Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer, 1, 115-124.
75. Asch, H.L., Eliacin, E., Fanning, T.G., Connolly, J.L., Bratthauer, G., Asch, B.B. (1996) Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues. Oncol. Res., 8, 239-247.
76. Beck, C.R., Collier, P., Macfarlane, C., Malig, M., Kidd, J.M., Eichler, E.E., Badge, R.M., Moran, J.V. (2010) LINE-1 retrotransposition activity in human genomes. Cell, 141, 1159-1170.
77. Brouha, B., Schustak, J., Badge, R.M., Lutz-Prigge, S., Farley, A.H., Moran, J.V., Kazazian, H.H. Jr. (2003) Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. U.S.A., 100, 5280-5285.
78. Seleme, M.C., Vetter, M.R., Cordaux, R., Bastone, L., Batzer, M.A., Kazazian, H.H. Jr (2006) Extensive individual variation in L1 retrotransposition capability contributes to human genetic diversity. Proc. Natl. Acad. Sci. U.S.A., 103, 6611-6616.
79. Lee, G.Y., Jang, J.S., Lee, S.Y., Jeon, H.S., Kim, K.M., Choi, J.E., Park, J.M., Chae, M.H., Lee, W.K., Kam, S. et al. (2005) XPC polymorphisms and lung cancer risk. Int. J. Cancer, 115, 807-813.
80. Becker, W. (2012) Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control. Cell Cycle, 11, 3389-3394.
81. Lucchinetti, E., Feng, J., Silva, R., Tolstonog, G.V., Schaub, M.C., Schumann, G.G., Zaugg, M. (2006) Inhibition of LINE-1 expression in the heart decreases ischemic damage by activation of Akt/PKB signaling. Physiol. Genomics, 25, 314-324.
82. Goodier, J.L., Cheung, L.E., Kazazian, H.H. Jr (2013) Mapping the LINE1 ORF1 protein interactome reveals associated inhibitors of human retrotransposition. Nucleic Acids Res., 41, 7401-7419.
83. Callahan, K.E., Hickman, A.B., Jones, C.E., Ghirlando, R., Furano, A.V. (2011) Polymerization and nucleic acid-binding properties of human L1 ORF1 protein. Nucleic Acids Res., 40, 813-827.
84. Kulpa, D.A., Moran, J.V. (2005) Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum. Mol. Genet., 14, 3237-3248.
85. Kulpa, D.A., Moran, J.V. (2006) Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat. Struct. Mol. Biol., 13, 655-660.
86. Reiter, R.J., Tan, D.X., Mayo, J.C., Sainz, R.M., Lopez-Burillo, S. (2002) Melatonin, longevity and health in the aged: an assessment. Free Radic. Res., 36, 1323-1329.
87. Schernhammer, E.S., Berrino, F., Krogh, V., Secreto, G., Micheli, A., Venturelli, E., Sieri, S., Sempos, C.T., Cavalleri, A., Schunemann, H.J. et al. (2008) Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst., 100, 898-905.
88. Fu, L., Pelicano, H., Liu, J., Huang, P., Lee, C. (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell, 111, 41-50.
89. Zheng, B., Larkin, D.W., Albrecht, U., Sun, Z.S., Sage, M., Eichele, G., Lee, C.C., Bradley, A. (1999) The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature, 400, 169-173.
90. Burgess, R.C., Misteli, T., Oberdoerffer, P. (2012) DNA damage, chromatin, and transcription: the trinity of aging. Curr. Opin. Cell Biol., 24, 724-730.
91. Gorbunova, V., Seluanov, A. (2005) Making ends meet in old age: DSB repair and aging. Mech. Ageing Dev., 126, 621-628.
92. Tan, D.X., Hardeland, R., Manchester, L.C., Paredes, S.D., Korkmaz, A., Sainz, R.M., Mayo, J.C., Fuentes-Broto, L., Reiter, R.J. (2010) The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol. Rev. Camb. Philos. Soc., 85, 607-623.
93. Xiong, Y., Eickbush, T.H. (1990) Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J., 9, 3353-3362.